Peer Review History
| Original SubmissionApril 29, 2025 |
|---|
|
Dear Dr. Lee, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 12 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Tahir Turk, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2 . Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information 3. Thank you for stating the following financial disclosure: “This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 816303” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. Thank you for stating the following in your Competing Interests section: “NO authors have competing interests” Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state "The authors have declared that no competing interests exist.", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 5. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 6. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. 7. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Unfortunately, we have only been able to identify one reviewer for your manuscript. However, we note very detailed feedback by the reviewer on ways to improve the manuscript for a second review noting that this is currently an under-studied topic for precision nutrition research. Please refer to the reviewer feedback below. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Summary: This paper sought to conduct a quasi-experimental study to understand the impact of certainty and sample type on responses and attitudes to personalized nutrition. Reviewer’s Comments: Overall: 1. This is an excellent paper investigating an under-studied topic part of precision nutrition research, that is important to understand in order to achieve success with PN based interventions. Introduction 2. Page 3, Line 80-87: The authors discuss multiple definitions of PN, but do not formally define PN for their study. Perhaps this is by design but it would be good to explicitly state that the authors are not going to define PN for use in this study, and rather the study aims to assess the pre-existing conceptualization of “personalized nutrition” at this point, without defining it. (See comment 4). 3. Page 5, Line 140-155: It is true that PN is a relatively nascent field (as noted in the Discussion) and there is a lot of uncertainty, but several human studies exist that the authors could cite as adding to the complexity. For example, Zeevi et al. 2015 (Cell) is motivating the NIH-funded Nutrition for Precision Health study in the United States, which is currently ongoing and aims to enroll 8000+ people to test responses to diet. Popp et al. 2022 (JAMA) tried to apply the same algorithm used in Zeevi et al. 2015 (Cell) but for weight loss rather than glucose control, and found null results unlike Zeevi which is an interesting discussion point. The PREDICT-1 and other PREDICT studies were also done in thousands of humans. Discussion of these and other studies, even if to highlight the uncertainties these studies may raise in terms of human work, should be considered for this paragraph. Methodology & Results 4. Page 8, Lines 238: How were participants recruited – targeted emails, a list serv, posters? 5. Page 8, Lines 238: How do you know participants are nationally representative? 6. Page 8, Line 248: What is a median age of 45-54? The median should be one number if representing the 261 individuals. Is this the IQR? Or is this 2 medians for the 2 different studies? 7. Either in main text or supplementary material, it would be helpful to have a table of characteristics for the participants of this study (unless age was the only demographic characteristic collected). 8. Page 8, Lines 238-248: Did you assess the level of participants’ baseline experience or knowledge with PN prior to the study? Such as, have they used mobile apps purporting to be based on precision nutrition? Was personalized nutrition defined for them in some way? I’m curious if participants understood what was meant by personalized nutrition – as simply one’s nutritional needs for height, weight, sex, physical activity – or with the additional variables mentioned in the introduction section that get closer to true individualization? Additionally, education level may influence results – see comment 8 below. I might hypothesize that those who say PN is ‘certain’ may not be as well educated about PN or nutrition in general? 9. Page 8, Lines 247-248: Participant median age of 45-54 – it would be interesting to break down the results by age group and see if there are differences between younger and older groups, considering openness to new technologies or concepts varying with age (I say this anecdotally) 10. Page 12: A Kruskal Wallis test is meant to test for differences between medians, not means. Elsewhere “median” is noted, though, so please check this is consistent throughout. 11. It would be useful to perhaps in Supplementary material, include the NHS guidelines for collecting the samples especially since the authors adapted them for this study. Adapted in what way? Identifying or accessing the specific guidelines used might not be straightforward for those outside the UK. Discussion: 12. Regarding comment 7, I see a lack of background info is noted in the Strengths and Limitations – it might be good to also note the types of characteristics that would be relevant to measure, and how they might be impact the results, even though you did not measure this. References: 13. Again please cite the major human studies in the field including Zeevi et al, etc. (see above). ********** [While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org
|
| Revision 1 |
|
Public perceptions of biospecimen sampling and uncertainty in the context of personalised nutrition PONE-D-25-20637R1 Dear Dr. Lee, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Tahir Turk, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: Thank you; All comments are addressed. I have no other comments. ............................................ ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** |
| Formally Accepted |
|
PONE-D-25-20637R1 PLOS ONE Dear Dr. Lee, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Tahir Turk Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .